Colleen Ngai

1.5k total citations
16 papers, 1.0k citations indexed

About

Colleen Ngai is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Colleen Ngai has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Colleen Ngai's work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipoproteins and Cardiovascular Health (8 papers) and Lipid metabolism and disorders (6 papers). Colleen Ngai is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipoproteins and Cardiovascular Health (8 papers) and Lipid metabolism and disorders (6 papers). Colleen Ngai collaborates with scholars based in United States, France and Canada. Colleen Ngai's co-authors include Henry N. Ginsberg, Rajasekhar Ramakrishnan, Benjamin Tycko, Gladys E. Maestre, Ruth Ottman, Richard Mayeux, Yaakov Stern, Ming‐Xin Tang, T. K. Tatemichi and Steve Holleran and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Diabetes Care.

In The Last Decade

Colleen Ngai

14 papers receiving 987 citations

Peers

Countries citing papers authored by Colleen Ngai

Since Specialization

Citations

This map shows the geographic impact of Colleen Ngai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Ngai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Ngai more than expected).

Fields of papers citing papers by Colleen Ngai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Ngai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Ngai. The network helps show where Colleen Ngai may publish in the future.

Co-authorship network of co-authors of Colleen Ngai

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Ngai. A scholar is included among the top collaborators of Colleen Ngai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Ngai. Colleen Ngai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Abstract 682: TM6SF2 is Necessary for the Late Addition of Lipid and Secretion of Fully-lipidated Very Low Density Lipoproteins From Hepg2 Cell 2019 ·Arteriosclerosis Thrombosis and Vascular Biology ·Jing Liu, Rebecca Perry, Colleen Ngai, Henry N. Ginsberg	0
2	Abstract 498: A Novel Human APOC2 Mutation Causes Severe Hypertriglyceridemia Due to Decreased Fractional Clearance Rates of Very Low Density Lipoprotein apoB and Triglyceride and Increased Production Rates of Very Low Density Lipoprotein Triglyceride 2019 ·Arteriosclerosis Thrombosis and Vascular Biology ·Gissette Reyes‐Soffer, (unknown), (unknown), Colleen Ngai, (unknown), Stephen Holleran, R Ramakrishnan, Henry N. Ginsberg	0
3	Effects of mipomersen, an apolipoprotein B100 antisense, on lipoprotein (a) metabolism in healthy subjects 2018 ·Journal of Lipid Research ·Renu Nandakumar, (unknown), Tiffany Thomas, (unknown), Colleen Ngai, Stephen Holleran, Rajasekhar Ramakrishnan, Henry N. Ginsberg, Wahida Karmally, Santica M. Marcovina, Gissette Reyes‐Soffer	43
4	Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism 2018 ·Arteriosclerosis Thrombosis and Vascular Biology ·Gissette Reyes‐Soffer, (unknown), Richard B. Horenstein, Stephen Holleran, (unknown), Tiffany Thomas, Renu Nandakumar, Colleen Ngai, Wahida Karmally, Henry N. Ginsberg, Rajasekhar Ramakrishnan, Toni I. Pollin	71
5	Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans 2016 ·Science Translational Medicine ·Gissette Reyes‐Soffer, Byoung C. Moon, Antonio Hernández‐Ono, (unknown), (unknown), Joseph C. Obunike, Tiffany Thomas, Colleen Ngai, Nelson Fontanez, Daniel S. Donovan, Wahida Karmally, Stephen Holleran, Rajasekhar Ramakrishnan, Robert S. Mittleman, Henry N. Ginsberg	22
6	Abstract 18390: Effects of a Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Inhibitor, Alirocumab, on Lipid and Lipoprotein Metabolism in Healthy Subjects 2015 ·Circulation ·Gissette Reyes‐Soffer, (unknown), Colleen Ngai, Tiffany Thomas, Stephen Holleran, (unknown), Wahida Karmally, Daniel Donovan, Lisa N. Cowan, William J. Sasiela, Howard K. Surks, (unknown), (unknown), Henry N. Ginsberg	1
7	Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial 2012 ·Diabetes Care ·Gissette Reyes‐Soffer, Colleen Ngai, Laura Lovato, Wahida Karmally, Rajasekhar Ramakrishnan, Stephen Holleran, Henry N. Ginsberg	37
8	Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus 2009 ·Journal of Lipid Research ·Gissette Reyes‐Soffer, Steve Holleran, Wahida Karmally, Colleen Ngai, (unknown), (unknown), Rajasekhar Ramakrishnan, William S. Blaner, Lars Berglund, Henry N. Ginsberg, Catherine H. Tuck	18
9	Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus 2005 ·Journal of Clinical Investigation ·Kazunori Nagashima, (unknown), Daniel Donovan, Colleen Ngai, Nelson Fontanez, André Bensadoun, Jamila Fruchart‐Najib, Steve Holleran, Jeffrey S. Cohn, Rajasekhar Ramakrishnan, Henry N. Ginsberg	153
10	Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus 2005 ·Journal of Clinical Investigation ·Kazunori Nagashima, (unknown), Daniel Donovan, Colleen Ngai, Nelson Fontanez, André Bensadoun, Jamila Fruchart‐Najib, Steve Holleran, Jeffrey S. Cohn, Rajasekhar Ramakrishnan, Henry N. Ginsberg	139
11	Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia 2005 ·Journal of Lipid Research ·Merle Myerson, Colleen Ngai, (unknown), Steve Holleran, Rajasekhar Ramakrishnan, Lars Berglund, Henry N. Ginsberg	32
12	A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E 1999 ·Journal of Lipid Research ·Yan Xu, Lars Berglund, Rajasekhar Ramakrishnan, Richard Mayeux, Colleen Ngai, (unknown), Benjamin Tycko, Todd Leff, Neil S. Shachter	61
13	Association of Apo E Polymorphism With Plasma Lipid Levels in a Multiethnic Elderly Population 1997 ·Arteriosclerosis Thrombosis and Vascular Biology ·Ariel Pablos-Méndez, Richard Mayeux, Colleen Ngai, Steven Shea, Lars Berglund	83
14	RELATIONSHIP OF APOPROTEIN-B AND APOPROTEIN-CIII POLYMORPHISMS WITH POSTPRANDIAL LIPEMIA 1995 ·UCL Discovery (University College London) ·R Ramakrishnan, Philippa J. Talmud, Steve E. Humphries, Colleen Ngai, Stephen Holleran, Melissa D. Begg, HN Ginsberg	1
15	The apolipoprotein ε4 allele in patients with Alzheimer's disease 1993 ·Annals of Neurology ·Richard Mayeux, Yaakov Stern, Ruth Ottman, T. K. Tatemichi, Ming‐Xin Tang, Gladys E. Maestre, Colleen Ngai, Benjamin Tycko, Henry N. Ginsberg	346
16	Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations. 1993 ·Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·H N Ginsberg, Colleen Ngai, (unknown), Rajasekhar Ramakrishnan	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact